Scientists Uncover the Hidden Mechanism Behind FDA-Approved Alzheimer’s Drug
Scientists show that lecanemab clears amyloid plaques by engaging microglia through its Fc fragment, defining the cellular program behind its therapeutic effect Lecanemab, marketed as Leqembi, is a monoclonal antibody…